Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis | Zendy

Arno Verleye | Zendy; Veerle Wijtvliet | Zendy; Steven Abrams | Zendy; Rachel Hellemans | Zendy; Rania Bougrea | Zendy; Annick Massart | Zendy; Lissa Pipeleers | Zendy; Karl Martin Wissing | Zendy; Kevin K. Ariën | Zendy; Benedicte Y. De Winter | Zendy; Pierre Van Damme | Zendy; Daniel Abramowicz | Zendy; Kristien J. Ledeganck | Zendy

Open Access

Seroconversion rate after primary vaccination with two doses of BNT162b2 versus mRNA-1273 in solid organ transplant recipients: a systematic review and meta-analysis

Author(s) -

Arno Verleye,

Veerle Wijtvliet,

Steven Abrams,

Rachel Hellemans,

Rania Bougrea,

Annick Massart,

Lissa Pipeleers,

Karl Martin Wissing,

Kevin K. Ariën,

Benedicte Y. De Winter,

Pierre Van Damme,

Daniel Abramowicz,

Kristien J. Ledeganck

Publication year - 2022

Publication title -

nephrology dialysis transplantation

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.654

H-Index - 168

eISSN - 1460-2385

pISSN - 0931-0509

DOI - 10.1093/ndt/gfac174

Subject(s) - seroconversion , medicine , vaccination , meta analysis , cochrane library , titer , population , antibody , immunology , environmental health

In the general population, the seroconversion rate after primary vaccination with two doses of an anti-severe acute respiratory syndrome coronavirus 2 messenger RNA (mRNA) vaccine reaches nearly 100%, with significantly higher antibody titers after mRNA-1273 vaccination compared to BNT162b2 vaccination. Here we performed a systematic review and meta-analysis to compare the antibody response after two-dose mRNA-1273 versus BNT162b2 vaccination in solid organ transplant (SOT) recipients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research